Yurpeak 2.5 Kwikpen

Yurpeak 2.5 mg/0.6ml Kwikpen is used in the treatment of type II Diabetes Mellitus. It is a viable alternative for supplementing the incretin effect in achieving glycemic control, as this impact is weakened in diabetes, with the additional benefits of glycosylated haemoglobin (HbA1c) reduction. It is also used to manage weight loss in obese people. It helps prolong the sensation of fullness and thereby promotes weight loss, cardiovascular health, a good lipoprotein profile, and improvement in nonalcoholic steatohepatitis.

Yurpeak 2.5 mg/0.6ml Kwikpen should be kept between 2°C and 8°C in the refrigerator. Avoid freezing or using it once frozen. Keep the medicine in its original container to keep it from light. Yurpeak 2.5 mg/0.6ml Kwikpen shouldn't be returned to the fridge if it has been kept at room temperature. If not utilized within 21 days of being removed from the refrigerator, discard.

Yurpeak 2.5 mg/0.6ml Kwikpen may cause serious adverse effects like thyroid C-cell tumours, pancreatitis, diabetic retinopathy complications, acute kidney injury, hypersensitivity, and acute gallbladder disease. Consult the doctor if you notice any unusual symptoms.

You should inform the doctor if you get eye problems, such as changes in vision, during treatment with this medicine as the Yurpeak 2.5 mg/0.6ml Kwikpen may lead to complications of diabetic eye disease (retinopathy). When taking this medication, you may feel nauseous, sick (vomiting), or have diarrhoea. These adverse effects may result in dehydration (loss of fluids). You must consume enough water to avoid dehydration, especially if you have kidney issues.

2 - 8°C

KwikPen